Condition: Multiple Sclerosis · Parkinson Disease · Amyotrophic Lateral Sclerosis · Sponsor: Neuromed IRCCS
A prospective and retrospective cohort study of about five years will be performed on blood and cerebrospinal fluid samples taken for diagnostic reasons from recruited patients within the Neuromed Neurology Unit. Subjects with other chronic neurodegenerative diseases such as Amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD) and Parkinson's disease (PD), and healthy subjects subjected to blood sampling and / or lumbar puncture for clinical reasons will be recruited As control groups.
This description comes directly from the study's public registry record.
Diego Centonze, MD · +39 3934444159 · centonze@uniroma2.it
Mario Stampanoni Bassi, MD · +39 3460181370 · mario_sb@hotmail.it
Always discuss trial participation with your own doctor first.
| IRCCS Neuromed | Pozzilli, Isernia, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03217396